NWBO (OTC)
NORTHWEST BIOTHRPUTCS INC
$0.233000
-0.007000 (-2.92%)
Prev close: $0.240000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Linda F. Powers
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $358.98M
- Employees
- 25
- P/E (TTM)
- -3.54
- P/B (TTM)
- -3.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-0.02 | $0.00 | +0.0000 | +0.00% |
|
Mar 2014 (Q1)
|
$-0.88 | $-0.40 | -0.4822 | -121.22% |
|
Dec 2013 (Q4)
|
$-0.40 | $-0.42 | +0.0182 | +4.35% |
|
Sep 2013 (Q3)
|
$-0.65 | $-0.33 | -0.3185 | -96.08% |
Financial Statements
| Revenues | $937.00K |
| Benefits Costs and Expenses | $24.29M |
| Costs And Expenses | -$24.87M |
| Operating Expenses | $65.85M |
| Depreciation and Amortization | $1.77M |
| Research and Development | $33.75M |
| Other Operating Expenses | $30.32M |
| Operating Income/Loss | -$64.91M |
| Income/Loss From Continuing Operations After Tax | -$89.75M |
| Income/Loss From Continuing Operations Before Tax | -$103.92M |
| Net Income/Loss | -$89.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $21.00K |
| Net Income/Loss Attributable To Parent | -$89.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$91.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.45M |
| Preferred Stock Dividends And Other Adjustments | $1.45M |
| Basic Earnings Per Share | -$0.07 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 1,452,175 |
| Diluted Average Shares | 1,452,175 |
| Assets | $30.61M |
| Current Assets | $7.20M |
| Noncurrent Assets | $23.41M |
| Fixed Assets | $16.87M |
| Other Non-current Assets | $6.54M |
| Liabilities | $125.86M |
| Current Liabilities | $87.91M |
| Noncurrent Liabilities | $37.95M |
| Long-term Debt | $72.20M |
| Equity | -$108.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$108.65M |
| Liabilities And Equity | $30.61M |
| Net Cash Flow From Operating Activities | -$50.18M |
| Net Cash Flow From Operating Activities, Continuing | -$50.18M |
| Net Cash Flow From Investing Activities | -$988.00K |
| Net Cash Flow From Investing Activities, Continuing | -$988.00K |
| Net Cash Flow From Financing Activities | $51.68M |
| Net Cash Flow From Financing Activities, Continuing | $51.68M |
| Net Cash Flow | $513.00K |
| Net Cash Flow, Continuing | $513.00K |
| Comprehensive Income/Loss | -$92.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$92.41M |
| Other Comprehensive Income/Loss | $10.69M |